PhRMA shames Brazil and Thailand over patent backlogs

Pharmaceutical Research and Manufacturers of America (PhRMA) has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

PhRMA members invested $71.4bn in R&D in 2017

13 August 2018 Members of the Pharmaceutical Research and Manufacturers of America last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development.

Americas

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

Big Pharma

PhRMA says EU, WTO, others are ‘weakening’ IP

7 February 2022 Pharmaceutical industry consortium PhRMA has asked the Office of the US Trade Representative to put the European Union, the World Trade Organization and the UK on a watch list of trading partners that could “weaken” IP rights.